The Michael J. Fox Foundation for Parkinson’s Research (MJFF) was founded in 2000 with one clear objective: accelerating meaningful therapeutic advances and, ultimately, a cure for Parkinson’s disease (PD). The Foundation applies extraordinary scientific, business and media assets to this singular focus—thus creating a unique and dynamic organization. Since inception, MJFF has quickly grown into the largest nonprofit funder of Parkinson’s disease research, having funded over $1 billion in research projects in both academic and industry labs worldwide.

Core to our philosophy is how we think of our capital and its risk profile relative to other stakeholders in the drug development pipeline. We work aggressively to de-risk various therapeutic strategies and tools in the hopes of building a robust pipeline of new treatments for patients. In order to achieve our mission of finding a cure for PD it is critical that we engage with, and bring together, members of the PD community including researchers, physicians, health professionals and most important, people with Parkinson's and their families.

We believe that to find a cure for PD as quickly as possible, our capital needs to push research forward today—we therefore deliberately hold no endowment or excessive reserves. We instead seek to deploy funds raised as quickly and wisely as possible. MJFF raises over $100 million annually. Today, the Foundation has approximately 186 full-time employees. We offer a collegial and collaborative environment where optimistic problem-solvers and entrepreneurial, resourceful individuals can thrive and make a tangible difference for millions of people living with Parkinson’s disease.